Projects per year
Fingerprint
Dive into the research topics where Richard Geoffrey Vile is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 11 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
-
-
Core A: Administrative Core
Gores, G. J., Vile, R. G., Leof, E. B., Roberts, L. R. & Roberts, L. R.
Project: Research project
-
Enhancing Therapy of Primary and Recurrent Tumors With Systemic Oncolytic Virus
Vile, R. G. & Kinney, L.
5/7/14 → 4/30/19
Project: Research project
-
Enhancing Systemic Delivery of Oncolytic Viruses for Cancer Therapy
Vile, R. G. & Kinney, L.
1/1/09 → 11/30/14
Project: Research project
-
Autoimmunity and anti tumor immunity outside of the melanocyte/melanoma paradigm
Vile, R. G. & Kinney, L.
7/1/08 → 5/31/14
Project: Research project
Research output
-
Synthetic and systems biology principles in the design of programmable oncolytic virus immunotherapies for glioblastoma
Monie, D. D., Bhandarkar, A. R., Parney, I. F., Correia, C., Sarkaria, J. N., Vile, R. G. & Li, H., Feb 2021, In: Neurosurgical focus. 50, 2, p. 1-11 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Ad-CD40L mobilizes CD4 T cells for the treatment of brainstem tumors
Wongthida, P., Schuelke, M. R., Driscoll, C. B., Kottke, T., Thompson, J. M., Tonne, J., Stone, C., Huff, A. L., Wetmore, C., Davies, J. A., Parker, A. L., Evgin, L. & Vile, R. G., Dec 1 2020, In: Neuro-oncology. 22, 12, p. 1757-1770 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy
Driscoll, C. B., Schuelke, M. R., Kottke, T., Thompson, J. M., Wongthida, P., Tonne, J. M., Huff, A. L., Miller, A., Shim, K. G., Molan, A., Wetmore, C., Selby, P., Samson, A., Harrington, K., Pandha, H., Melcher, A., Pulido, J. S., Harris, R., Evgin, L. & Vile, R. G., Dec 1 2020, In: Nature communications. 11, 1, 790.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Brain cancer induces systemic immunosuppression through release of non-steroid soluble mediators
Ayasoufi, K., Pfaller, C. K., Evgin, L., Khadka, R. H., Tritz, Z. P., Goddery, E. N., Fain, C. E., Yokanovich, L. T., Himes, B. T., Jin, F., Zheng, J., Schuelke, M. R., Hansen, M. J., Tung, W., Parney, I. F., Pease, L. R., Vile, R. G. & Johnson, A. J., Dec 1 2020, In: Brain. 143, 12, p. 3629-3652 24 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer
Crespo-Rodriguez, E., Bergerhoff, K., Bozhanova, G., Foo, S., Patin, E. C., Whittock, H., Buus, R., Haider, S., Muirhead, G., Thway, K., Newbold, K., Coffin, R. S., Vile, R. G., Kim, D., McLaughlin, M., Melcher, A. A., Harrington, K. J. & Pedersen, M., Aug 5 2020, In: Journal for ImmunoTherapy of Cancer. 8, 2, 698.Research output: Contribution to journal › Article › peer-review
Open Access